In light of the society's action, its Technologist Section "will shape and define its role in molecular imaging," according to SNMTS President D. Scott Holbrook. "SNMTS knows the importance--and value--of developing well-rounded technologists who can work in PET/CT, SPECT/CT, research, and information technology and understand cross-sectional anatomy, contrast media, and instrumentation. We want to help develop a curriculum to prepare technologists to take advantage of the opportunities offered by these advances in molecular imaging," added the vice president of Clinical Pharmacy Services, an independent nuclear pharmacy in Gray, Tenn.
Over the next three to five years, SNM intends define itself as its' members' indispensable resource for education, knowledge exchange, training and networking; as the powerful advocate for molecular medicine, including imaging and therapy; as the leader in education and in promoting collaboration with referring physician and patient groups; as a significant supporter of innovations in translational research; and as the society that positions molecular medicine as an essential tool in providing the highest standards of patient care around the world.
According to Sandler, these goals affirm SNM's most recent action: embarking on a five-year $5 million "Bench to Bedside: A Molecular Imaging Campaign" to fund outreach activities to referring physicians and patient groups, support translational clinical studies and small innovative trials and offer research grants and fellowships to advance new medical developments.
'"/>
Contact: Maryann Verrillo
mverrillo@snm.org
703-708-9000
Society of Nuclear Medicine
2-Aug-2006